(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 10.29% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.64%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.21%.
Stevanato Group Spa's revenue in 2023 is $933,488,888.On average, 4 Wall Street analysts forecast STVN's revenue for 2023 to be $311,736,812,133, with the lowest STVN revenue forecast at $305,972,599,271, and the highest STVN revenue forecast at $314,108,816,462. On average, 3 Wall Street analysts forecast STVN's revenue for 2024 to be $339,439,257,407, with the lowest STVN revenue forecast at $334,610,428,759, and the highest STVN revenue forecast at $345,453,201,600.
In 2025, STVN is forecast to generate $372,064,217,521 in revenue, with the lowest revenue forecast at $372,064,217,521 and the highest revenue forecast at $372,064,217,521.